Omada Health (OMDA) revenue and earnings history
Omada Health reported revenue of $260M for fiscal 2025 (year ended Dec 31, 2025), +53.2% on the year before, and net income of −$12.8M.
Over 2 years, from fiscal 2023 to fiscal 2025, revenue grew at a compound rate of +45.6% a year.
Revenue and net income, 3 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $260M+53.2% | −$12M | −$12.8M | $18.3M | $1.32M | $16.9M | $13M | — | — | $222M | $0 | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Omada Health (OMDA) on OQRO.
Common questions
What was Omada Health's revenue in fiscal 2025?
$260M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 6, 2026. That is +53.2% on fiscal 2024 ($170M).
How fast has Omada Health's revenue grown?
From $123M in fiscal 2023 to $260M in fiscal 2025: a compound annual growth rate of +45.6% over 2 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Omada Health been profitable?
It reported a net loss in 3 of the years shown (2023, 2024, 2025). The highest net income was −$12.8M in fiscal 2025.
Where these figures come from
The SEC’s companyfacts data: every figure Omada Health tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.